How to localize parathyroid tumors in primary hyperparathyroidism?

Journal of Endocrinological Investigation

Volumn 29, Issue 9, 2006, Pages 840-847

  Uruno, T ^a   Kebebew, E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CT; MIBI; MRI; Primary hyperparathyroidism; Sestamibi; Ultrasonography

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE; PERTECHNETIC ACID TC 99M;

COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; HUMAN; MINIMALLY INVASIVE SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HYPERPLASIA; PARATHYROID SCINTISCANNING; PARATHYROID TUMOR; PARATHYROIDECTOMY; PEROPERATIVE CARE; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; RECURRENT DISEASE; SENSITIVITY ANALYSIS; SHORT SURVEY; SURGICAL TECHNIQUE; TUMOR LOCALIZATION; VEIN CATHETERIZATION;

EID: 33845334508     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347381     Document Type: Short Survey

References (47)

1. Kebebew E, Clark OH. Parathyroid adenoma, hyperplasia, and carcinoma: localization, technical details of primary neck exploration, and treatment of hypercalcemic crisis. Surg Oncol Clin N Am 1998, 7: 721-48.
2. Palazzo FF, Delbridge LW. Minimal-access/minimally invasive parathyroidectomy for primary hyperparathyroidism. Surg Clin North Am 2004, 84: 717-34.
3. Siperstein A, Berber E, Mackey R, Alghoul M, Wagner K, Milas M. Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery 2004, 136: 872-80.
4. Grant CS, Thompson G, Farley D, van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 2005, 140: 472-8.
5. Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 2002, 235: 665-70.
6. Coakley AJ, Kettle AG, Wells CR, O'Doherty MJ, Collins RE. 99Tcm sestamibi - a new agent for parathyroid imaging. Nucl Med Commun 1989, 10: 791-4.
7. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(l) in cultured mouse fibroblasts. J Nucl Med 1990, 31: 1646-53.
8. Hetrakul N, Civelek AC, Stagg CA, Udelsman R. In vitro accumulation of technetium-99m-sestamibi in human parathyroid mitochondria. Surgery 2001, 130: 1011-8.
9. Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med 2005, 35: 266-76.
10. Mehta NY, Ruda JM, Kapadia S, Boyer PJ, Hollenbeak CS, Stack BC Jr. Relationship of technetium Tc 99m sestamibi scans to histopathological features of hyperfunctioning parathyroid tissue. Arch Otolaryngol Head Neck Surg 2005, 131: 493-8.
11. Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005, 132: 359-72.
12. Pappu S, Donovan P, Cheng D, Udelsman R. Sestamibi scans are not all created equally. Arch Surg 2005, 140: 383-6.
13. Lorberboym M, Ezri T, Schachter PP. Preoperative technetium Tc 99m sestamibi SPECT imaging in the management of primary hyperparathyroidism in patients with concomitant multinodular goiter. Arch Surg 2005, 140: 656-60.
14. Ryan JA Jr, Lee FT. Maximizing outcomes while minimizing exploration in hyperparathyroidism using localization tests. Arch Surg 2004, 139: 838-42.
15. Gotthardt M, Lohmann B, Behr TM, et al. Clinical value of parathyroid scintigraphy with technetium-99m methoxyisobutylisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature. World J Surg 2004, 28: 100-7.
16. Hajioff D, Iyngkaran T, Panagamuwa C, Hill D, Stearns MP. Preoperative localization of parathyroid adenomas: ultrasonography, sestamibi scintigraphy, or both? Clin Otolaryngol Allied Sci 2004, 29: 549-52.
17. Profanter C, Wetscher GJ, Gabriel M, et al. CT-MIBI image fusion: a new preoperative localization technique for primary, recurrent, and persistent hyperparathyroidism. Surgery 2004, 135: 157-62.
18. Kebapci M, Entok E, Kebapci N, Adapinar B. Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy. J Endocrinol Invest 2004, 27: 24-30.
19. Clark PB, Case D, Watson NE Jr, Perrier ND, Morton KA. Enhanced scintigraphic protocol required for optimal preoperative localization before targeted minimally invasive parathyroidectomy. Clin Nucl Med 2003, 28: 955-60.
20. Sebag F, Hubbard JG, Maweja S, Misso C, Tardivet L, Henry JF. Negative preoperative localization studies are highly predictive of multiglandular disease in sporadic primary hyperparathyroidism. Surgery 2003, 134.
21. Wakamatsu H, Noguchi S, Yamashita H, et al. Parathyroid scintigraphy with 99mTc-MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography. Nucl Med Commun 2003, 24: 755-62.
22. Lorberboym M, Minski I, Macadziob S, Nikolov G, Schachter P. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med 2003, 44: 904-8.
23. Sekiyama K, Akakura K, Mikami K, et al. Usefulness of diagnostic imaging in primary hyperparathyroidism. Int J Urol 2003, 10: 7-11.
24. Haber RS, Kim CK, Inabnet WB. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m)technetium sestamibi scintigraphy. Clin Endocrinol (Oxf) 2002, 57: 241-9.
25. Civelek AC, Ozalp E, Donovan P, Udelsman R. Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery 2002, 131: 149-57.
26. Berczi C, Mezosi E, Galuska L, et al. Technetium-99m-sestamibi/ pertechnetate subtraction scintigraphy vs ultrasonography for preoperative localization in primary hyperparathyroidism. Eur Radiol 2002, 12: 605-9.
27. Panzironi G, Falvo L, De Vargas Macciucca M, et al. Preoperative evaluation of primary hyperparathyroidism: role of diagnostic imaging. Chir Ital 2002, 54: 629-34.
28. Scheiner JD, Dupuy DE, Monchik JM, Noto RB, Cronan JJ. Pre-operative localization of parathyroid adenomas: a comparison of power and colour Doppler ultrasonography with nuclear medicine scintigraphy. Clin Radiol 2001, 56: 984-8.
29. Arici C, Cheah WK, Ituarte PH, et al. Can localization studies be used to direct focused parathyroid operations? Surgery 2001, 129: 720-9.
30. Lumachi F, Tregnaghi A, Zucchetta P, et al. Technetium-99m sestamibi scintigraphy and helical CT together in patients with primary hyperparathyroidism: a prospective clinical study. Br J Radiol 2004, 77: 100-3.
31. Casara D, Rubello D, Pelizzo MR, Shapiro B. Clinical role of 99mTcO4/ MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. Eur J Nucl Med 2001, 28: 1351-9.
32. Shon IH, Roach PJ, Bernard E, Fulcher G, Delbridge L. Superimposed double parathyroid adenoma on Tc-99m MIBI imaging: the value of oblique images. Clin Nucl Med 2001, 26: 876-7.
33. Wakamatsu H, Noguchi S, Yamashita H, et al. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)TI, MRI and US. Eur J Nucl Med 2001, 28: 1817-27.
34. Dackiw AP, Sussman JJ, Fritsche HA Jr, et al. Relative contributions of technetium Tc 99m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism. Arch Surg 2000, 135: 550-5.
35. Lumachi F, Ermani M, Basso S, Zucchetta P, Borsato N, Favia G. Localization of parathyroid tumours in the minimally invasive era: which technique should be chosen? Population-based analysis of 253 patients undergoing parathyroidectomy and factors affecting parathyroid gland detection. Endocr Relat Cancer 2001, 8: 63-9.
36. Moka D, Voth E, Dietlein M, Larena-Avellaneda A, Schicha H. Technetium 99m-MIBI-SPECT: A highly sensitive diagnostic tool for localization of parathyroid adenomas. Surgery 2000, 128: 29-35.
37. De Feo ML, Colagrande S, Biagini C, et al. Parathyroid glands: combination of (99m)Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology 2000, 214: 393-402.
38. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992, 33: 1801-7.
39. Billotey C, Sarfati E, Aurengo A, et al. Advantages of SPECT in technetium-99m-sestamibi parathyroid scintigraphy. J Nucl Med 1996, 37: 1773-8.
40. Gayed IW, Kim EE, Broussard WF, et al. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med 2005, 46: 248-52.
41. Royal RE, Delpassand ES, Shapiro SE, et al. Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression. Surgery 2002, 132: 968-74.
42. Makras P, Kaltsas GA, Athanasoulis T, et al. Treatment with oral biphosphonates can increase the sensitivity of sestamibi radionuclide imaging in patients with primary hyperparathyroidism. Int J Clin Pharmacol Res 2005, 25: 19-28.
43. Friedman K, Somervell H, Patel P, et al. Effect of calcium channel blockers on the sensitivity of preoperative 99mTc-MIBI SPECT for hyperparathyroidism. Surgery 2004, 136: 1199-204.
44. Ulanovski D, Feinmesser R, Cohen M, Sulkes J, Dudkiewicz M, Shpitzer T. Preoperative evaluation of patients with parathyroid adenoma: role of high-resolution ultrasonography. Head Neck 2002, 24: 1-5.
45. Rickes S, Sitzy J, Neye H, Ocran KW, Wermke W. High-resolution ultrasound in combination with colour-Doppler sonography for preoperative localization of parathyroid adenomas in patients with primary hyperparathyroidism. Ultraschall Med 2003, 24: 85-9.
46. Lumachi F, Zucchetta P, Marzola MC, et al. Advantages of combined technetium-99m-sestamibi scintigraphy and high-resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism. Eur J Endocrinol 2000, 143: 755-60.
47. Jones JJ, Brunaud L, Dowd CF, Duh QY, Morita E, Clark OH. Accuracy of selective venous sampling for intact parathyroid hormone in difficult patients with recurrent or persistent hyperparathyroidism. Surgery 2002, 132: 944-50.